Your browser doesn't support javascript.
loading
Torsemide in the Management of Essential Hypertension.
Bhattacharyya, Kuntal; Tiwaskar, Mangesh; Datta, Arnab; Chandani, Arti Lal; Agrawal, Santosh Kumar; Abdullakutty, Jabir; Badani, Rajesh; Doshi, Dhaval; Singh, Vikas; Advani, Prashant; Varghese, Kiron; Pandey, Ajay Kumar; Francis, Febin; Sugumaran, Amarnath.
Afiliación
  • Bhattacharyya K; Consultant Interventional Cardiologist, Department of Cardiology, Narayana Hospital - RN Tagore Hospital, Kolkata, West Bengal, India, Corresponding Author.
  • Tiwaskar M; Consultant Physician and Diabetologist, Department of Medicine, Shilpa Medical Research Centre, Mumbai, Maharashtra, India.
  • Datta A; Consultant Interventional Cardiologist and Ex Assistant Professor, Department of Cardiology, Medical College, Kolkata, West Bengal, India.
  • Chandani AL; Senior Interventional Cardiologist, Department of Cardiology, Kanpur, Uttar Pradesh, India.
  • Agrawal SK; Senior Interventional Cardiologist, Department of Cardiology, Kailash Hospital and Heart Institute, Noida, Uttar Pradesh, India.
  • Abdullakutty J; Senior Consultant Cardiologist, Department of Cardiology, Lisie Heart Institute, Kochi, Kerala, India.
  • Badani R; Senior Consultant, Interventional Cardiologist and Electrophysiologist, Department of Cardiology, Aditya Birla Memorial Hospital, Pune, Maharashtra, India.
  • Doshi D; Consultant and Interventional Cardiologist, Department of Cardiology, Holistic Heart Care, Ahmedabad, Gujarat, India.
  • Singh V; Senior Consultant Interventional Cardiologist, Department of Cardiology, Mediversal Hospital, Patna, Bihar, India.
  • Advani P; Consultant Cardiologist, Department of Cardiology, Advani Heartline and Metabolic Centre, Raipur, Chhattisgarh, India.
  • Varghese K; Senior Interventional Cardiologist and Professor, Department of Cardiology, St. John's Medical College Hospital, Bengaluru, Karnataka, India.
  • Pandey AK; Senior Consultant Interventional Cardiologist, Department of Cardiology, Galaxy Hospital, Varanasi, Uttar Pradesh, India.
  • Francis F; Medical Advisor, Medical Affairs, Cipla Ltd., Mumbai, Maharashtra, India.
  • Sugumaran A; Medical Advisor, Medical Affairs, Cipla Ltd., Mumbai, Maharashtra, India.
J Assoc Physicians India ; 72(9S): 35-37, 2024 Sep.
Article en En | MEDLINE | ID: mdl-39291572
ABSTRACT
Torsemide, a loop diuretic, is increasingly recognized for its role in managing essential hypertension. Its mechanism of action involves inhibiting the reabsorption of sodium and chloride ions in the ascending loop of Henle in the kidneys. By doing so, torsemide promotes diuresis, which refers to increased urine production, and subsequently lowers blood pressure. Studies have shown that torsemide is comparably effective to other antihypertensive agents in lowering blood pressure, with the added benefit of potentially improving renal function. However, while torsemide shows promise in hypertensive management, further research is necessary to fully understand its long-term effects and to establish optimal dosing strategies. Future research should focus on clarifying its role in long-term blood pressure control and refining its use in clinical practice to maximize efficacy and minimize adverse effects.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores del Simportador de Cloruro Sódico y Cloruro Potásico / Hipertensión Esencial / Torasemida / Hipertensión / Antihipertensivos Límite: Humans Idioma: En Revista: J Assoc Physicians India Año: 2024 Tipo del documento: Article Pais de publicación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores del Simportador de Cloruro Sódico y Cloruro Potásico / Hipertensión Esencial / Torasemida / Hipertensión / Antihipertensivos Límite: Humans Idioma: En Revista: J Assoc Physicians India Año: 2024 Tipo del documento: Article Pais de publicación: India